Gene Therapy Approach Shows Encouraging Signs Against Ovarian Cancer

A single injection of a gene therapy viral vector can deliver effective and long-lasting levels of a protein that inhibits the growth of some mouse tumors derived from patients with recurrent ovarian cancer, according to a new study published July 27 in the Proceedings of the National Academy of Sciences.Mullerian inhibiting substance (MIS) is a protein produced in the male

Too Few Patients with Cancer Communicate Preferences for End-of-Life Care

Many patients with cancer are not communicating their preferences for end-of-life medical care either through written documents or discussions with loved ones, a new study suggests. The study also found a large increase in the number of people receiving intensive treatment in the last days and weeks of their lives.The results, published online July 9 in JAMA Oncology, underscore the

Ask any Question Navtej kohli on GlassDoor Become a Friend on Navtej kohli Linkedin